Clinical Trial Update: Safety and Efficacy of Empagliflozin in Hemodialysis [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial, sponsored by NYU Langone Health, is evaluating the safety and efficacy of empagliflozin in patients on hemodialysis with end-stage …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: NYU Langone Health | Conditions: End Stage Renal Disease | Phase 2 | Status: RECRUITING